TNF and inflammatory bowel disease: Nonetheless, a contradictory result was reported by an international registry where thiopurine monotherapy and combination therapy with a TNF antagonist in IBD patients were associated with an increased risk of severe SARS-CoV-2 outcomes, encompassing ICU admissions, mechanical ventilation, or death [7].